| Stage | ETN | % of rev | EPAC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.9B | 100.00% | $186M | 100.00% | ETN ×48.17 |
| Gross profit | $3.1B | 34.70% | $87M | 47.07% | EPAC +12.4pp |
| Operating income | $1.6B | 17.76% | $34M | 18.48% | EPAC +0.7pp |
| Pre-tax income | $1.4B | 15.31% | $31M | 16.76% | EPAC +1.5pp |
| Net income | $1.1B | 12.06% | $24M | 13.17% | EPAC +1.1pp |
| Stage | ETN | EPAC | Gap · A − B |
|---|---|---|---|
| Revenue | $8.9B100.00% | $186M100.00% | ETN ×48.17 |
| Gross profit | 34.70%$3.1B | 47.07%$87M | EPAC +12.4pp |
| Operating income | 17.76%$1.6B | 18.48%$34M | EPAC +0.7pp |
| Pre-tax income | 15.31%$1.4B | 16.76%$31M | EPAC +1.5pp |
| Net income |
| 12.06%$1.1B |
| 13.17%$24M |
| EPAC +1.1pp |
No disclosed counterparties: EPAC.
None